navelbine 10 mg/ml koncentrátum oldatos infúzióhoz
pierre fabre médicament - vinorelbine -
navelbine 20 mg lágy kapszula
pierre fabre médicament - vinorelbine -
navelbine 30 mg lágy kapszula
pierre fabre médicament - vinorelbine -
navelbine 80 mg lágy kapszula
pierre fabre médicament - vinorelbine -
vinorelbin alvogen 20 mg lágy kapszula
zentiva, k.s. (csehország) - vinorelbine -
vinorelbin alvogen 30 mg lágy kapszula
zentiva, k.s. (csehország) - vinorelbine -
zoledronsav ranbaxy 4 mg/5 ml koncentrátum oldatos infúzióhoz
ranbaxy uk ltd. - zoledronsav -
navelbin 10 mg/1 ml injekció
pierre fabre médicament -
navelbin 50 mg/5 ml injekció
pierre fabre médicament - vinorelbine -
imjudo
astrazeneca ab - tremelimumab - carcinoma, hepatocellular - daganatellenes szerek - imjudo in combination with durvalumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc). imjudo in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.